The company has established a price range of 129 to 136 per equity share for its initial public offering.
The initial public offering (IPO) of Kronox Lab Sciences Limited began today. The public issue worth 130.15 crore will remain open for bidders until June 5th, 2024. The public issue will remain open for bidders until June 5th, 2024. The book build issue is complete, and offering for sale, which means the IPO won’t have any immediate impact on the company’s balance sheet. The firm has established a price range of 129 to 136 per equity share for the initial public offering of Kronox Lab Sciences. According to stock market observers, Kronox Lab Sciences Limited shares have become available in the grey market. Today’s grey market has a premium of 83 for shares of Kronox Lab Sciences.
The initial public offering (IPO) of Kronox Lab Sciences is scheduled for Monday, June 3, 2024. The book-built issue aims to raise Rs 130.15 crores, with a total fresh issue of 0.96 crore shares.
The launch of Kronox Lab Sciences.
Chittorgarh IPO platform claims the latest grey market premium (GMP) for Kronox Lab Sciences IPO is Rs 82. The estimated listing price for the initial public offering (IPO) is Rs 218, representing a projected listing gain of 60.29 percent per share.
Financials from the IPO of Kronox Lab Sciences.
Revenue increased by 16.8 percent to Rs 97.50 crore in FY23 from Rs 83.34 crore in FY22, from Rs 83.34 crore in FY22. In FY23, it reported a profit after tax of Rs 16.62 crore, up 23 percent from the previous year.
Kronox Lab sciences IPO lead book runners Kronox Lab sciences IPO lead book runners
The Kronox Lab Sciences IPO is managed by Pantomath Capital Advisors Pvt Ltd, while Kfin Technologies Limited is the registrar.
Kronox Labs IPO allotment.
The company has allocated not more than 50 percent of the shares offered of the net Issue to qualified institutional buyers and investors. 35 percent of the net issue is earmarked for retail buyers, and 15 percent for non-institutional investors.
The IPO of Kronox Lab Sciences
Kronox Lab Sciences Limited was established in 2008 and produces high-purity specialty fine chemicals for a variety of industries. It supplies to India and over 20 countries, including the US, Australia, and China, with over 185 products. It exports via seaports from its three facilities in Vadodara, Gujarat, with three facilities in Gujarat. Quality-certified, it conducts research and development on 122 items and serves 592 clients, including 141 regulars. With 212 employees, it’s committed to sustaining expansion and achieving excellence in chemical production.
Specialty fine chemicals are manufactured for diverse end-user industries. Chemicals from the company are used in applications such as manufacturing APIs, pharmaceutical formulations, scientific research, and nutraceuticals among other products.
KRONOX Lab Sciences Ltd is engaged in the production of high-purity fine chemicals, inorganic chemicals, phosphates, and metallic chemicals. Product development and production have been instrumental to our achievements in providing innovative and affordable products to domestic and international markets. We have a large manufacturing plant and the most modern quality control system.
Kronox Lab Sciences IPO subscription status is IPO subscription status.
Half an hour after the IPO opened, the book build issue was flooded with subscribers. By 12:15 PM on day one of bidding, the public issue had been booked 3.84 times, the retail portion had been booked 5.59 times, and the NII segment had been subscribed 4.88 times.
Key events for the IPO of Kronox Lab Sciences
The Kronox Lab Sciences IPO opens for subscription on June 3, 2024, and closes on June 5, 2024, The Kronox Lab Sciences IPO is expected to be finalized on Thursday, June 6, 2024. The tentative listing date for Kronox Lab Sciences IPO is Monday, June 10, 2024.
Important information about the initial public offering of Kronox Lab Sciences.
Observers say shares of Kronox Lab Sciences are trading at a premium of 83 on the black market today.
The company has fixed the Kronox Lab Sciences IPO price at 129 to 136 per equity share.
The book build issue for Kronox Lab Sciences opened today and will remain open until June 5, 2024.
An entirely open-for-sale offering will raise 130.15 crore for Kronox Lab Sciences.
There are 110 company shares in a lot size for the Kronox Lab Sciences IPO.
Informationgraphic: Courtesy mintgenieView Full Image.
Infographic courtesy of mintgenie.
The date for the IPO of Kronox Lab Sciences is June 6, 2024.
Kronox Lab Sciences has appointed KFin Technologies Limited as the official registrar of the public issue.
The public issue is proposed for listing on BSE and NSE for Kronox Lab Sciences IPO.
In the wake of the ‘T+3’ listing rule, the public issue of Kronox Lab Sciences is expected to hit Dalal Street on Monday, June 10th, 2024.
Do you apply or not?
Kronox Lab Sciences IPO review: On whether the IPO is good or bad for primary market investors, Asit C Mehta reports.
A 16-member research, development, and testing laboratory is housed within the CompaCompany to develop new products and evaluate existing ones against specified industry standards or customer requirements. It continues to broaden its product portfolio to meet the ever-evolving requirements of the end-user sectors.
Also, read Walmart earnings are raised.
Axis Capital said that the company’s revenues from operations grew at a CAGR of 23.70% between Fiscal 2021 and 2023, from 62.46 crore to 95.58 crore, while its EBITDA grew at a CAGR of 21.90 percent. Between Fiscal 2021 and Fiscal 2023, the companies’ PAT grew by 30.68 percent from 9.73 crore to 16.62 crore. The company has a strong balance sheet and cash flow position and is zero-debt.
Swastika Investment has given the initial public offering a buy rating, whereas SMC Global and JM Financial haven’t given the book production issue a buy rating.
Disclaimer: This data is gathered from online resources for information purposes only.